| ²é¿´: 3127 | »Ø¸´: 7 | |||
lb1527½ð³æ (СÓÐÃûÆø)
|
[ÇóÖú]
¸å¼þ±»¾Ü£¬±à¼¸øÁËÁíÍâÍÆ¼öÔÓÖ¾£¬²»ÏëͶ£¬ÎÒÓ¦¸ÃÔõô¸øÖ®Ç°µÄ±à¼»Ø¸å¼þÄØ~¼±Çó~ ÒÑÓÐ6È˲ÎÓë
|
|
¸å¼þ±»¾Ü£¬±à¼¸øÁËÁíÍâµÄÒ»¸öÍÆ¼öÔÓÖ¾£¬¿ÉÊÇÄǸöÔÓÖ¾·ÇSCI£¬ÎÒÓ¦¸ÃÔõô¸øÖ®Ç°µÄ±à¼»Ø¸å¼þÄØ~¼±Çó~ Thank you very much for the opportunity to consider your manuscript "Ameliorative effects of a promising AChE inhibitor nootkatone on impaired learning behavior in A¦Â1-42-injecet mouse" for publication in Drugs & Aging. We regret that we are unable to consider your paper for publication in this journal, as Drugs & Aging does not generally publish preclinical animal studies of this kind. However, the topic is of interest for our sister journal, Drugs in R & D, and we would like to recommend that this article be considered for publication in this journal. Drugs in R & D is a Medline-indexed, peer-reviewed journal and accepts research on drugs in every stage of development. The journal is an 'open-access' journal, i.e. if accepted for publication, your paper will be freely available to readers all over the world from the journal home page on SpringerLink. As an open access journal, Drugs in R & D does not have paying subscribers and therefore manuscript processing and publishing charges are normally recouped via the Article Processing Charge (APC). However, as this is a recommended transfer from Drugs & Aging, the Editor would be prepared to waive the usual charge if you choose to transfer your submission. As with all Adis manuscripts, your manuscript will be independently peer reviewed and edited by experts. Further information about this journal can be found at www.Springer.com/journal/40268. We look forward to hearing from you shortly. With kind regards, |
» ²ÂÄãϲ»¶
±¾ÈË¿¼085602 »¯Ñ§¹¤³Ì ר˶
ÒѾÓÐ23È˻ظ´
Çóµ÷¼ÁԺУÐÅÏ¢
ÒѾÓÐ4È˻ظ´
085600²ÄÁÏÓ뻯¹¤306
ÒѾÓÐ4È˻ظ´
286Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
328Çóµ÷¼Á£¬Ó¢ÓïÁù¼¶551£¬ÓпÆÑоÀú
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ070300 ѧ˶336Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
286·ÖÈ˹¤ÖÇÄÜרҵÇëÇóµ÷¼ÁÔ¸Òâ¿ç¿¼£¡
ÒѾÓÐ8È˻ظ´
×ÊÔ´Óë»·¾³ µ÷¼ÁÉêÇë(333·Ö)
ÒѾÓÐ5È˻ظ´
280Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
269ר˶Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
µÚÒ»´ÎͶ¸å ÔÆÀïÎíÀïµÄ ±à¼»ØÐÅ ´ó¼Ò¸øÎÒ¿´¿´ ÎÒÐèÒª×öʲô°¡
ÒѾÓÐ3È˻ظ´
¸å¼þÏÈǰ±»Ä³ÔÓ־ûÓÐËÍÉó¾ÍÍÆ¼öµ½ÆäËüÔÓÖ¾£¬Ä¿Ç°´óÐÞºóÏëÔÚͶ»ØÔÔÓÖ¾
ÒѾÓÐ3È˻ظ´
Ò»¸å¶àͶÁË£¬Ôõô°ì£¿
ÒѾÓÐ12È˻ظ´
ÔÀ´±ð¾Ü¾øµÄ¸å¼þ£¬ÔÙ´ÎͶÏòÔºÔÓÖ¾É磬»á²»»áÖ±½ÓÔÙ±»¾Ü£¿
ÒѾÓÐ19È˻ظ´
ÂÛÎı»Â¼ÓÃÁË£¬Í¨Öª½»°æÃæ·Ñ£¬ÎÒÓÐʵ¢¸é£¬¹ýÁËʮһÌìÁË»¹Ã»½»£¬»á²»»á×Ô¶¯Í˸壿
ÒѾÓÐ3È˻ظ´
¼ÓÃÁ˵ÄÂÛÎĽÐÎÒÒª²»Òªopen access£¬²»Ï뽻ǮÎÒÓ¦¸ÃÔõô»Ø£¿
ÒѾÓÐ26È˻ظ´
ÓÐÒ»¸öÉó¸åÈËûÓÐÒâ¼û£¬ÎÒÐèÒªÔÚÒâ¼û»ØÖ´ÐÅÖиÐлËûÂð£¿Èç¹ûÐèÒª£¬¸ÃÔõÑùд£¿
ÒѾÓÐ22È˻ظ´
SCI´óÐÞ£¬ÇëÎÊÎÒ¿ÉÒÔÖØÐ¸ÄͶÆäËûÆÚ¿¯Âð£¿
ÒѾÓÐ22È˻ظ´
ΪʲôÍùµçÍø¼¼ÊõÔÓ־Ͷ¸åºó£¬ºÃ¼¸Ìì±à¼²¿¶¼Ã»ÓпªÊ¼´¦Àí¸å¼þ
ÒѾÓÐ4È˻ظ´
ÈçºÎѯÎʱ༸å¼þÊÇ·ñÊʺϴËÔÓÖ¾·¢±í
ÒѾÓÐ8È˻ظ´
¸å¼þ±»AÔÓÖ¾¾ÜÁË£¬Í¶¸åµ½BÔÓÖ¾£¬BÔÓÖ¾ÒªÇóÈ·ÈÏÒÔÏÂÄÚÈÝ¡£ÔõôÌ
ÒѾÓÐ8È˻ظ´
¸ñʽ²»¶ÔµÄ¸å¼þ±»Í˻أ¨µ«¸øÁ˸åºÅ£©£¬Ïë¸ÄͶÆäËûÔÓÖ¾¿ÉÒÔÂð
ÒѾÓÐ8È˻ظ´
Ͷ¸åʱ£¬ÒªÇó×Ô¼ºÍƼöÆÀÉóÈË£¬ÎÒÐèÒªÌáǰ¸æÖªÎÒÍÆ¼öµÄÆÀÉóÈËÂð£¿
ÒѾÓÐ6È˻ظ´
ÎÄÕÂÔÚÐ޸ģ¬Éó¸ãÈË˵²Î¿¼ÎÄÏ×ÒýÓõò»ºÃ£¬ÎÒÓ¦¸ÃÈçºÎ¸Ä²¢ÈçºÎ»Ø¸´ËûÄØ
ÒѾÓÐ15È˻ظ´
ÎÒÐèÒª¸ø±à¼Ð´³·¸åÐÅÂð
ÒѾÓÐ12È˻ظ´
ACAµÄ¸å¼þÎÒûÓм°Ê±µÄÉóÍ꣬±à¼Ð´ÐÅ´ßÁË£¬ÆäËûÔÓÖ¾µÄÒ²»áÕâô¸ºÔðô£¿
ÒѾÓÐ4È˻ظ´
±»¾ÜÁË£¬ÏëÉêËßÄØ£¬´ó¼Ò°ïæ¿´¿´¾Ü¸åÐÅ£¬»¹ÓÐûÓпÉÄÜ£¿
ÒѾÓÐ13È˻ظ´
±à¼ÉÃ×ÔÔÚÎÒµÄ×ÛÊöÎÄÕÂÀïÃæ¼ÓÁ˱¾¿ÆÊÒһλÀÏʦµÄÃû×Ö£¬ÎÒÓ¦¸ÃÔõô°ì£¿
ÒѾÓÐ44È˻ظ´
Ïò¸÷λÇë½Ì¸ÃÔõô»ØÐÅ
ÒѾÓÐ5È˻ظ´
Ê·èÉôÁ
Ìú³æ (³õÈëÎÄ̳)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 217.5
- Ìû×Ó: 15
- ÔÚÏß: 4.9Сʱ
- ³æºÅ: 2646780
- ×¢²á: 2013-09-11
- ÐÔ±ð: MM
- רҵ: °²È«¿ÆÑ§Ó빤³Ì

2Â¥2014-03-21 13:36:44
makunjida
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
- Ó¦Öú: 1291 (½²Ê¦)
- ½ð±Ò: 17869.3
- É¢½ð: 481
- ºì»¨: 38
- Ìû×Ó: 7547
- ÔÚÏß: 399Сʱ
- ³æºÅ: 1578528
- ×¢²á: 2012-01-15
- רҵ: ¼ÆËã»úÈí¼þ
3Â¥2014-03-21 14:41:35
lb1527
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 139 (¸ßÖÐÉú)
- ½ð±Ò: 851.4
- ºì»¨: 3
- Ìû×Ó: 211
- ÔÚÏß: 52.4Сʱ
- ³æºÅ: 2347914
- ×¢²á: 2013-03-15
- רҵ: ÖÐҩҩЧÎïÖÊ
4Â¥2014-03-21 14:51:05
huicun
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 87 (³õÖÐÉú)
- ½ð±Ò: 861.2
- É¢½ð: 3279
- ºì»¨: 15
- Ìû×Ó: 1012
- ÔÚÏß: 353.9Сʱ
- ³æºÅ: 2026781
- ×¢²á: 2012-09-24
- רҵ: ½¨Öþ»·¾³Óë½á¹¹¹¤³Ì

5Â¥2014-03-21 16:14:43
ws861227
Ìú³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 611 (²©Ê¿)
- ½ð±Ò: 1908.2
- É¢½ð: 594
- ºì»¨: 9
- Ìû×Ó: 1159
- ÔÚÏß: 65.9Сʱ
- ³æºÅ: 1703734
- ×¢²á: 2012-03-20
- רҵ: Ë®ÎÄ¡¢Ë®×ÊÔ´
6Â¥2014-03-21 17:31:46
gaojunhn
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 85 (³õÖÐÉú)
- ½ð±Ò: 5167.5
- É¢½ð: 200
- ºì»¨: 19
- Ìû×Ó: 944
- ÔÚÏß: 750.6Сʱ
- ³æºÅ: 855843
- ×¢²á: 2009-09-24
- רҵ: ʳÓÃÕæ¾úѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
lb1527: ½ð±Ò+3, ¡ïÓаïÖú 2014-03-22 12:55:31
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
lb1527: ½ð±Ò+3, ¡ïÓаïÖú 2014-03-22 12:55:31
|
»ØÐÅ˵Äã²»ÏëͶ°¡ ÕâÖÖÇé¿ö±ØÐëÒª»Ø°¡ Â¥É϶¼ÊÇû¿´ÇåÓʼþ¾ÍÂÒ´ð È˼ÒÃ÷Ã÷˵ÁË We look forward to hearing from you shortly. ¶øÇÒÄãµÄ¸å¼þ״̬Ҳ²»ÊǾܸå ÕâÖÖÇé¿öͶÆäËûÔÓÖ¾²»¾ÍÊÇÒ»¸å¶àͶÂ𣿠|

7Â¥2014-03-21 19:08:32
wangjun890
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
- Ó¦Öú: 1067 (²©ºó)
- ½ð±Ò: 21565.8
- ºì»¨: 36
- Ìû×Ó: 6730
- ÔÚÏß: 552.1Сʱ
- ³æºÅ: 575839
- ×¢²á: 2008-06-19
- רҵ: ´ß»¯»¯Ñ§
8Â¥2014-03-21 19:30:56













»Ø¸´´ËÂ¥